Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nelia González-Droguett has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: Lizama-Lefno et al. Invisible Pain, Visible Inequalities: Gender, Social Agency, and the Health of Women with Fibromyalgia. Healthcare 2025, 13, 3143

    by Andrea Lizama-Lefno, Ángel Roco-Videla, Erick Atenas-Núñez, Nelia González-Droguett, María Jesús Muñoz-Yánez, Sergio V. Flores-Carrasco

  • Open Access

    Invisible Pain, Visible Inequalities: Gender, Social Agency, and the Health of Women with Fibromyalgia

    by Andrea Lizama-Lefno, Ángel Roco-Videla, Erick Atenas-Núñez, Nelia González-Droguett, María Jesús Muñoz-Yánez, Sergio V. Flores-Carrasco

    Background: Fibromyalgia (FM) is a chronic nociplastic pain condition predominantly affecting women. Although often addressed within biomedical frameworks, its structural and relational dimensions remain underexplored. This study examined how social, familial, and economic factors are associated with symptom severity and self-perceived mental health among women with FM, with particular emphasis on social participation and perceived discrimination. Methods: A cross-sectional study was conducted among women diagnosed with FM in Chile. Participants were recruited through patient organizations and community networks and completed a self-administered questionnaire covering biopsychosocial aspects of FM. Multifactor ANOVA models were used to explore associations between social and familial variables and symptom count and perceived mental health. Results: Participants were mostly middle-aged women who reported a high burden of symptoms and moderate levels of self-perceived mental health. Involvement in FM-related organizations was significantly associated with differences in symptom perception and better mental health, while perceived discrimination was linked to poorer mental health outcomes. Conclusions: Social participation and supportive environments emerge as potential determinants of health among women with FM. Primary care providers should adopt social and gender-sensitive approaches that acknowledge the influence of discrimination, economic vulnerability, and support networks in shaping the illness experience.


  • Open Access

    Association between Drug Use and Perception of Mental Health in Women Diagnosed with Fibromyalgia: An Observational Study

    by Andrea Lizama-Lefno, Krystel Mojica, Ángel Roco-Videla, Juan Ignacio Vargas Ruiz-Tagle, Nelia González-Droguett, María Jesús Muñoz-Yánez, Erick Atenas-Núñez, Nelson Maureira-Carsalade, Sergio Flores Carrasco

    Background/Objectives: Fibromyalgia (FM) is a chronic syndrome characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and mental health issues. It affects approximately 1.78% of the general population; an estimated 4:1 ratio between women and men is observed. It significantly impacts quality of life and carries both clinical and social stigma. This study aims to evaluate the relationship between drug use and mental health in female patients with fibromyalgia. Methods: This study is prospective, observational, and cross-sectional. A questionnaire was administered to 544 subjects, achieving a representative sample size from a population of 800,000 subjects by using an algorithm for proportion estimation with a known sampling frame. The selection was non-random, making the sampling non-probabilistic. Logistic regression models were applied to assess the effect of drug use on perception of mental health; presence of symptoms such as comprehension and memory problems, insomnia, depression, and anxiety; and severity of cognitive symptoms and non-restorative sleep. To quantify the impact, odds ratios and confidence intervals have been observed. Results: The findings indicate the non-recommended use of medications and reveal the ineffectiveness and adverse effects of drug interactions on mental health. The use of benzodiazepines and sedative-hypnotics is significantly associated with a negative perception of mental health. Benzodiazepines do not improve symptoms or significantly reduce their severity. SSRI antidepressants do not enhance mental health perception; however, when used exclusively, they are effective in reducing the severity, but not the prevalence, of cognitive symptoms. Conclusions: The results highlight the complexity of pharmacological management in FM and raise concerns about the inappropriate use of ineffective or counterproductive drug interactions affecting patients’ mental health. They underscore the need for multidisciplinary and personalized strategies that include close and careful monitoring, as well as the simultaneous use of non-pharmacological treatments that have demonstrated evidence in improving quality of life without negatively affecting mental health, such as patient education, psychological therapy, physiotherapy, and mindfulness.